Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China flag China · Delayed Price · Currency is CNY
7.06
-0.01 (-0.14%)
Mar 11, 2026, 3:00 PM CST
-55.29%
Market Cap 2.83B
Revenue (ttm) 1.06B
Net Income (ttm) -168.12M
Shares Out 400.11M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,957,300
Average Volume 3,493,439
Open 7.08
Previous Close 7.07
Day's Range 7.01 - 7.08
52-Week Range 6.50 - 18.30
Beta 0.57
RSI 51.71
Earnings Date Apr 30, 2026

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China. [Read more]

Sector Healthcare
Founded 2005
Employees 2,103
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605199
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.